Friday Reads for Investors: Smart Friday Reads to End Week
Kick off your weekend with a thoughtful set of friday reads designed to inform, not echo headlines. This guide blends...
Best Dividend ETFs highlights top options for generating income and potential appreciation. This intro guides you through evaluating yields and costs.
13,171 articlesKick off your weekend with a thoughtful set of friday reads designed to inform, not echo headlines. This guide blends...
BlackRock’s DYNF uses active factor rotation to chase leadership across value, quality, momentum, and more. As market...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Markets often misread good news when it signals a larger shift. This piece explores how talks, strategic reserves, an...
Eli Lilly has enjoyed rapid growth from GLP-1 drugs, but sky-high expectations invite questions about valuations. Thi...
A concise look at the weapons that altered modern warfare and how investors are pricing defense tech in 2026.
Microsoft kicks off 2026 with a rough start as earnings beat clashes with a surge in capital expenditures. Traders de...
Three months into 2026, the 2.8% COLA boosted average benefits to $2,071, but a surge in energy prices and Medicare w...
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
When the market shakes, a top-tier stock can become a compelling bargain. This guide breaks down why one Magnificent ...
Playnance's G Coin transitions from launch hype to a durability-focused utility test, as real-time staking and on-cha...
PennantPark Investment’s hefty yield hinges on a reserve that funds part of its payouts and a portfolio heavy in floa...